Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$715,412
+$94,914 QoQ
Shares Held
2,843
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2,853
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRILLIUM ASSET MANAGEMENT, LLC holds $65,640,925 across 8 Drug Manufacturers - General names. ABBV ranks #6 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
208,971 | $39,625,081 | |
| 2 | MRK |
Merck & Co., Inc.
|
87,017 | $11,181,684 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
75,118 | $9,490,408 | |
| 4 | JNJ |
Johnson & Johnson
|
11,314 | $2,873,416 | |
| 5 | NVO |
Novo Nordisk A S
|
19,689 | $943,890 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
2,843 | $715,412 | |
| 7 | LLY |
ELI LILLY & Co
|
359 | $430,595 | |
| 8 | PFE |
Pfizer Inc
|
15,799 | $380,439 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $715,412 | 2,843 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $620,498 | 2,853 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $609,382 | 2,667 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $617,517 | 2,667 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $497,832 | 2,682 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $557,113 | 2,659 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $472,504 | 2,659 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $511,078 | 2,588 | Shares | Defined | 2024-11-07 | |
| 2024-06-30 | $473,909 | 2,763 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $503,142 | 2,763 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $472,348 | 3,048 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $505,909 | 3,394 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $666,374 | 4,946 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $806,571 | 5,061 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $805,787 | 4,986 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $669,171 | 4,986 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $763,655 | 4,986 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $1,468,878 | 9,061 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $1,202,487 | 8,881 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $784,538 | 7,273 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $750,520 | 6,663 | Shares | Defined | 2021-11-12 | |
| 2021-03-31 | $731,783 | 6,762 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $724,548 | 6,762 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $805,477 | 9,196 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $716,026 | 7,293 | Shares | Sole | 2020-08-06 | |
| No filing history on record for this holder in this stock. | ||||||